RenaCare Dialysis Clinic Business Plan › Section 13 › Strategic Analysis

13.1 SWOT Analysis

The SWOT analysis below synthesises the strategic position of
Renacare at the point of commissioning. It is the product of multiple
workshops between the executive team and clinical advisors, validated
against external industry research.

Figure 13.1

13.2 Strategic Themes

The most important strategic insight from the SWOT, Porter’s Five
Forces and scenario analyses is that Renacare’s business model is
structurally attractive — high barriers to entry, recurring revenue, PMB
protection — but depends critically on successful execution of a small
number of operational levers. Strategy is simple in concept and
demanding in execution.

• Theme 1: Clinical excellence as a commercial moat. Demonstrated
  outcomes superior to the market average command premium tariffs and
  drive referrer loyalty.
• Theme 2: Lean cost advantage. Standalone operational model offers
  10–15% structural cost advantage versus hospital-embedded units; this
  must be preserved as the business scales.
• Theme 3: Payer diversification. Over-reliance on any single
  medical-aid scheme is the largest commercial risk; PPP and
  hospital-partnership revenue streams diversify this.
• Theme 4: Replicability over size. The 20-station model proven in
  the flagship site should be the template for all future clinics.
  Operational standardisation beats operational scale.
• Theme 5: Patient experience as brand. Dialysis is a commoditised
  clinical intervention; the patient’s lived experience is the true
  differentiator and the foundation of organic growth.

13.3 Growth Strategy

Renacare’s growth strategy prioritises depth of excellence at a
single site before breadth of expansion. The five-year horizon plans are
outlined below:

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of RenaCare Dialysis Clinic (Pty) Ltd.